Daniel Jerico
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
New cases of δ-aminolevulinic acid dehydratase deficiency: Functional insights into gene variants using an innovative mouse liver model.
Journal: Journal of internal medicine
Published: November 21, 2025
Oral lipoteichoic and lipoic acids improve insulin resistance and body composition in porphyria mice on a high-carbohydrate diet.
Journal: Journal of physiology and biochemistry
Published: May 22, 2025
Exploring current and emerging therapies for porphyrias.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 29, 2024
Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria.
Journal: International journal of molecular sciences
Published: June 29, 2023
The Alpha-Lipoic Acid Improves Glucose Metabolism and Hyperinsulinemia in Acute Intermittent Porphyria: A Nutritional Concept for the Management of Rare Disorders.
Journal: Cellular and molecular gastroenterology and hepatology
Published: June 19, 2023
Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria.
Journal: International journal of molecular sciences
Published: November 15, 2022
Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment.
Journal: Life (Basel, Switzerland)
Published: October 20, 2022
Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases.
Journal: International review of cell and molecular biology
Published: September 05, 2022
Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria.
Journal: Science translational medicine
Published: January 12, 2022
Last Updated: 09/26/2026